XML 27 R17.htm IDEA: XBRL DOCUMENT
v3.19.1

Accumulated other comprehensive loss | 3 Months Ended
--- | ---
Mar. 31, 2019
Accumulated other comprehensive loss | NOTE 10 – Accumulated other comprehensive loss: The components of, and changes within, accumulated other comprehensive losses attributable to Teva are presented in the table below:
|  | Net Unrealized Gains/(Losses) |  |  | Benefit Plans |  |  |  |
|  | Foreign currency translation adjustments |  |  | Available- for- sale securities |  |  | Derivative financial instruments |  |  | Actuarial gains/(losses) and prior service (costs)/credits |  |  | Total |
|  | (U.S.$ in millions) |
Balance as of December 31, 2017* |  | $ | (1,316 | ) |  | $ | 1 |  |  | $ | (442 | ) |  | $ | (91 | ) |  | $ | (1,848 | )
Other comprehensive income (loss) before reclassifications |  |  | 156 |  |  |  | 1 |  |  |  | (51 | ) |  |  | — |  |  |  | 106 |
Amounts reclassified to the statements of income |  |  | — |  |  |  | — |  |  |  | 7 |  |  |  | — |  |  |  | 7 |
Net other comprehensive income (loss) before tax |  |  | 156 |  |  |  | 1 |  |  |  | (44 | ) |  |  | — |  |  |  | 113 |
Net other comprehensive income (loss) after tax* * |  |  | 156 |  |  |  | 1 |  |  |  | (44 | ) |  |  | — |  |  |  | 113 |
Balance as of March 31, 2018 |  | $ | (1,160 | ) |  | $ | 2 |  |  | $ | (486 | ) |  | $ | (91 | ) |  | $ | (1,735 | )
* | Following the adoption of ASU 2016-01, the Company recorded a $ 5 million opening balance reclassification from accumulated other comprehensive income to retained earnings.
** | Amounts do not include a $ 83 million gain from foreign currency translation adjustments attributable to non-controlling interests.
|  | Net Unrealized Gains/(Losses) |  |  | Benefit Plans |  |  |  |
|  | Foreign currency translation adjustments |  |  | Available- for- sale securities |  |  | Derivative financial instruments |  |  | Actuarial gains/(losses) and prior service (costs)/credits |  |  | Total |
|  | (U.S.$ in millions) |
Balance as of December 31, 2018 |  | $ | (2,055 | ) |  | $ | 1 |  |  | $ | (327 | ) |  | $ | (78 | ) |  | $ | (2,459 | )
Other comprehensive income (loss) before reclassifications |  |  | 53 |  |  |  | — |  |  |  | 40 |  |  |  | — |  |  |  | 93 |
Amounts reclassified to the statements of income |  |  | — |  |  |  | — |  |  |  | 7 |  |  |  | — |  |  |  | 7 |
Net other comprehensive income (loss) before tax |  |  | 53 |  |  |  | — |  |  |  | 47 |  |  |  | — |  |  |  | 100 |
Net other comprehensive income (loss) after tax* |  |  | 53 |  |  |  | — |  |  |  | 47 |  |  |  | — |  |  |  | 100 |
Balance as of March 31, 2019 |  | $ | (2,002 | ) |  | $ | 1 |  |  | $ | (280 | ) |  | $ | (78 | ) |  | $ | (2,359 | )
* | Amounts do not include a $6 million loss from foreign currency translation adjustments attributable to non-controlling interests.

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration